The Use of Patient-Reported Outcome Measures in Paediatric Haematopoietic Stem Cell Transplant: A Systematic Review

Rachel Penny1,2, Samantha Keogh2,3,4, Jill Shergold2

  • 1Cancer and Palliative Care Outcomes Centre, Centre for Children's Health Research, Queensland University of Technology, Brisbane, QLD 4101, Australia.

Insights

Patient-Reported Outcome Measures (PROMs) are underused in pediatric Haematopoietic Stem Cell Transplantation (HSCT). Routine integration is needed to improve symptom management and patient care during HSCT.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Nursing
  • Health Services Research

Background:

  • Children and adolescents undergoing Haematopoietic Stem Cell Transplantation (HSCT) experience significant, often under-reported symptoms.
  • Patient-Reported Outcome Measures (PROMs) can capture patient experiences but their routine use in pediatric HSCT is unclear.

Purpose of the Study:

  • To systematically review the use of PROMs in inpatient pediatric HSCT care.
  • To examine the role of PROMs in symptom monitoring and clinical decision-making.
  • To identify gaps for improving person-centered, developmentally appropriate care.

Main Methods:

  • Systematic review of studies published 2014-2025 in major databases.
  • Included studies on PROMs use during inpatient pediatric HSCT (0-18 years) up to Day +100.
  • Narrative synthesis informed by Symptom Management Theory; Quality Assessment with Diverse Studies (QuADS) tool used.

Main Results:

  • Seventeen studies described 20 PROMs for pediatric HSCT hospitalisation.
  • PROMs captured physical/psychological symptoms (pain, nausea most frequent); improved detection/communication reported.
  • Integration into routine clinical care was rare; limited evidence of PROMs-driven outcome improvements.

Conclusions:

  • PROMs are not routinely integrated into clinical practice for pediatric HSCT.
  • Current evidence offers a limited view of symptom trajectories and lived experiences.
  • Systematic integration into workflows, EHRs, clinician training, and longitudinal research are needed.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408